HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Kiat Ruxrungtham is currently working HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
His research interest is based on Assessment of HIV.
He has published many articles in reputed journals
One of his famous publications is Low-Dose Ritonavir-Boosted Atazanavir (200/100 mg) Maintained a High Virological Efficacy Up To 4 Years in Treatment-Experienced HIV-1 Infected Adults: A Prospective Cohort Study from Asia
Low dose atazanavir/ritonavir; Plasma ATV concentrations; HIV-infected patients; Thailand
Journal of AIDS & Clinical Research received 5264 citations as per Google Scholar report